Ernest Fokoue
Professor
Ernest Fokoue
Professor
Bio
I have been around Mathematical Sciences from my very early childhood, and I have always greatly enjoyed the beauty and power that mathematics affords to problem solving. Statistical Science in particular and specifically Statistical Machine Learning and Data Science are my passion, my profession and to some extent my vocation. The flexibility and power of probabilistic reasoning along with the richness and vast applicability of statistical models both fascinate and enthuse me immensely. My mission as a professor of statistical science is to generously, joyfully and rigorously share the full extent of my knowledge and expertise in this exciting field with the ultimate goal of empowering all the students that God graciously sends my way. Indeed, I always envision my students acquiring state-of-the-art knowledge in statistical science and ultimately developing into world class experts and pioneers.
Select Scholarship
Currently Teaching
In the News
-
September 23, 2022
AI summit brings together an exciting range of research underway
Applications being developed at RIT using artificial intelligence vary from sophisticated medical monitoring devices to the development of autonomous systems for Indy racecars. These represent some of the exciting and complex work underway at the university that will be featured prominently at the AI@RIT Summit: Discovering and Harnessing the Breadth and Depth of Artificial Intelligence at RIT.
-
August 17, 2021
RIT scientists model how coronavirus attaches itself to human cells
RIT scientists have uncovered new information about the way coronavirus and several of its variants attach to human cells. The researchers examined how coronaviruses use their spike proteins to attach themselves to the host cells they are attacking.
-
May 8, 2020
Daily dose of COVID-19 numbers: Advice for sorting out what's important
WHAM-TV talks to Ernest Fokoue, professor in the School of Mathematical Sciences, about sorting out COVID-19 data.
-
April 26, 2021
Babbitt leads cancer drug study